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INTRODUCTION 
 Depression disorder is one of the most 
common mental illness in the world and became 
a very important area of research interest in 
psychopharmacology. Major depressive disorder 
(MDD) is characterized by a lowered mood. The 
working mechanism of AD is believed to be either 
by increased neurotransmission by increased 
synaptic levels of serotonin, norepinephrine (NE) and 
dopamine (DA) (monoamines)1. The increased levels 
of monoamines were discoveredin the late fifties, 
when the TCAs and Monoamine oxidase A inhibitors 
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ABSTRACT
 Based on a traditional belief, Echium amoenum (Boraginaceae) dried flowers are used in 
Iran as an anxiolytic remedy and also as a mood enhancer. But interfering mechanisms unknown, 
In this study, efficacy of an aqueous extract of E.amoenum in depressive rat was evaluated, using 
measurement the changes level CSF serotonin and dopamine as indicator mood. Four groups 
of male wistar rats each group of seven rats were enrolled in this study. Depressive induced with 
intraperitoneal injection of reserpine (5mg/kg) and assessment depression by swimming test, the 
next two weeks of oral performing aqueous extract Echium amoenum, CSF serotonin and dopamine 
concentration of rats were measured using ELISA kit. Our finding indicated, performing aqueous 
extract Echium amoenum increased CSF serotonin and dopamine concentration in depression 
rats. The level of CSF serotonin enhanced in control group receiving Echium amoenum compared 
control group alone.  These results showed the serious changes of neurotransmitters due to Echium 
amoenum which can be translated as mood enhancer. It can be concluded, Echium amoenum induce 
antidepressant effective in part by increasing level CSF serotonin and dopamine. 
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(MAO-I) appeared to effectively treat MDD. This 
discovery resulted to the monoamine hypothesis: 
MDD might etiologically be explainedby a deficiency 
in monoamine neurotransmitters: serotonin (5-HT), 
NE or DA2,3. Desire in alternative medicine and 
plant-derived medications that affect the ‘mind’ is 
developing. Self administration of herbal medicines 
was the most popular alternative treatments to 
the official medicine. The application of herbal 
medications is becoming very common by physicians 
in Europe and Asia and researchers are exploring 
the traditional remedies to find a fit cure for these 
‘mind affecting diseases’.Moreover, Iranian climate 
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and favored geographical location have contributed 
to the diversity of medicinal plants.Borage (Echium 
amoenum) is a wild annual herb that belongs to 
Boraginaceae family which grows in large parts of 
Europe, Mediterranean region, and also in parts of 
Iran4. The flowers and the leaves of borage are used 
medicinally in the West and iran for the treatment of 
Stress, analgesic, anxiolytic, sedative, circulatory 
heart diseases, pulmonary complaints and other 
psychiatric illnesses4-7. Volatile constituents of 
E.amoenum was extracted by Ghassemi et al, These 
compounds include octadecane, heptadecane, 
viridiflorol, alpha cadinen etc8. Toxic pyrolizidine 
alkaloids of E. amoenum were separated by 
Mehrabani et al.,9. It has been shown that flavonoids 
possess mild sedative and anxiolytic effects, the 
naturally occurring flavonoids and their synthetic 
derivatives have been revealed to bind selectively 
to the central benzodiazepine receptors and to us 
anxiolytic and other benzodiazepine like effects in 
animals10.The anxiolytic and antidepressant effect of 
the flower of Echium amoenum was demonstrated in 
several experimental studies in mice and human9,11. 
Despite the widespread use of E. amoenum as an 
antidepressant , there are no pharmacological data 
of antidepressant mechanism of E. amoenum . The 
aim of the present study was to evaluate effect the 
aqueous extract of E. amoenum on changes the level 
of CSF serotonin and dopamine as indicator mood 
in depression rat. 
 
EXPERIMENTAL 
Plant material an. Extraction 
 An aqueous extract (pH=6) of dried flowers 
was used in this study. E.amoenum flowers were 
collected from Ilam district, Iran. Flowers of this 
plant were separated and dried in roomtemperature 
(22-24 °C). The plant materials were powdered 
and exhaustively extracted with distilled water in a 
Soxhlet apparatus under reduced pressure. After 
evaporation of the solvent in rotary evaporator and 
then in oven at 40 °C, the residue was diluted with 
salinefor obtain the desire concentration (125 mg/
kg ). 
Animals 
 The experiment was conducted,using four 
groups (seven rat each)weighed 250-300g. The 
animals were kept in a 25±2 °C temperature with a 
12 hr light /dark cycle and fed with standarddiet and 
tap drinking water. Animals were randomly divided 
into 4 groups; control ,depression, control + Echium 
amoenum and depression+ Echium amoenum,The 
rats were acclimatized to the laboratory for at least 1 
h before oral performing of aqueous extractEchium 
amoenum(125mg/kg)and were administrated 
extraction CSF after two weeks of treatment,The 
experiments were carried out between 9.00 and 
14.00 h. The experimental protocol was approved 
byof Animal house and Ethical Committee at Ilam 
University of Medical Sciences (IUMS). 
Porsolt swim test for assessment depression 
 The procedure for the Porsoltforced swim 
test was as previously reported (Porsolt, LePichon, 
and Jalfre, 1977). By administrating depression 
rats with intraperitoneal injection of reserpine-
sigma(5mg/kg) (12) and assessment depression 
by swimming test, Briefly, rats were placed in a 
cylindrical container (40 cm deep, 27 cm in diameter) 
filled with 30 cm of 30°C water. The amount of time 
the rats spent swimming or immobile was recorded in 
a 10-min test. Swimming was defined as movement 
of the forelimbs and hindlimbs without the front 
paws breaking the surface of the water. Immobility 
was recorded when there was an absence of any 
movement other than that necessary to keep the 
head andnose above the water (e.g., when rats were 
floating in a vertical position). 
CSF sampling 
 The rats were anesthetized with 40 mg kg 
of sodium thiopental, intrapritonal andplaced in a 
stereotaxic frameand implanted with a guide cannula 
which was an insulin syringe (27 gauge 31/ 20 length 
by direct puncture of the cisterna magna was drawn 
CSF (40–60 micro liter per rat), CSF was collected 
from each rat (13). 
Neurotransmitters analysis 
 The level serotonin and dopamine of CSF 
samples were measured using the IBL international 
GMBH ELISA kit (Germany) and LDN GMBH Kit 
according to the manufacturer instruction (14, 15, 
16). The procedures for each neurotransmitter is 
summarized as follows. 
Serotonin ELISA 
 20 µL of each Control and sample was 
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pipetted into glass test tubes the 100 µL of diluted 
Assay Buffer was added to each tube. Vortex.Then 
25 µL of Acylation Reagent 1 (3 %) Pipetted into 
each tube. Vortex each tube immediately after pipe 
ting. Cover tubesIncubated 15 min at 37°C in a water 
bath, Then 4 mL of diluted Assay Buffer was Pipetted 
into each tube. Vortex. The all tubes Centrifuged for 
10 min at 1500 x g. immediately Prepared samples 
assayed, The supernatant was stabled for only 1 h 
at 18-25°C. 
Dopamine ELISA 
 In the first 25 µl of the Enzyme Solution 
was pipetted into all wells of the Dopamine Microtiter 
Strips. Then was added 100 µl of the standards, 
controls and samples into the appropriate wells 
incubated for 30 min at RT on a shaker (approx. 600 
rpm) and also 50 µl Dopamine antiserum was added 
to the wells and the plate covered with adhesive 
Foil, then incubated for 2 hours at RT on a shaker. 
3 times washing content of the wells and discarding 
followed by using 300 µl washing buffer. Next stage 
was added 100 µl of enzyme conjugate into all wells 
incubating 30 min at RT on a shaker. After washing, 
100 µl of the substrate was added into all wells and 
incubated for 20-30 min at RT followed by adding 
100 µl of the stop solution to each well and reading 
the absorbance of the solution in the wells within 10 
minutes, using a micro plate reader set to 450 nm 
and a reference wavelength between 620 nm and 
650 nm. 
Statistical analysis 
 Results are presented as mean±S.E.M. 
ANOVA was used for compare serotonin and 
dopamine in each group of 7 rat. Normality of data 
in each group was checked using one sample 
kolmogroror- simirnov test, Dennett test was 
performed as a post hoc multiple comparison 
analysis,P- value <0.05 was significantstatistically. 
 
RESULTS 
Effect of Echium amoenum aqueousextract on 
changes level CSF serotonin 
 Figure 1 display, the effect of aqueous 
extract of Echium amoenumon on changes level 
CSF serotonin in different groups, ANOVA analysis 
indicated the differences between various groups 
(P<0.05), the following analysis with Dunnett- test 
(Table 1) showed that changes level serotonin in 
the control group with the depression group and 
depression group receiving Echium amoenum was 
statically significant(P<0.05). However, the difference 
between depression group with depression group 
receiving Echium amoenum was statically significant 
(P<0.05). whereas for the other cases, it was 
not. In tables and figures con equal control, dep 
(depression) and Ech (Echium amoenum). 
Effects of Echium amoenum aqueous extract on 
changes level CSF dopamine 
 Figure 2 indicate, the effect of aqueous 
extract of Echium amoenumon on changes level 
CSF dopamine in different groups, ANOVA analysis 
indicated the differences between various groups 
(P<0.05), the following analysis with Dunnett- test 
(Table2) showed that changes level dopamine in 
the control group with the depression group was 
statically significant(P<0.05). However, the difference 
between depression group with depression group 
receiving Echium amoenum was statically significant 
(P<0.05). Whereas for the other cases, it was not. 
Table 1: The effect of aqueous extract Echium amoenum with dose 125 mg/kg after two 
weeks of oral performing on changes level CSF serotonin in different groups. Data are 
presented as mean values (“S.E.M.) from a group of 7 rat each. P-0.05 compared with control 
Dependent Variable J group I group  Mean  Std.  Sig. 
   Difference  Error   
   (J-I)  
CSF serotonin Control Depression  -8.25714  1.06954  .000 
 Control Depression+Ech -2.21429*  61994.  .004 
 Control+Ech Depression+Ech  -1.25714  61994.  .131 
 Depression Depression+Ech  -2.65714  .61994  .001 
140 FARYADIAN et al., Biomed. & Pharmacol. J.,  Vol. 7(1), 137-142 (2014)
Table 2: The effect of aqueous extract Echium amoenum with dose 125 mg/kg after two weeks 
of oral performing on changes level CSF dopamine in different groups. Data are presented 
as mean values ("S.E.M.) from a group of 7 rat each. P-0.05 compared with control 
Dependent Variable J group I group  Mean  Std.  Sig. 
   Difference  Error   
   (J-I)  
CSFdopamine Control Depression -8.25714 1.06954 .000
 Control Depression+Ech .04286 .04041 .590
 Control +Ech Depression+Ech .10000 .04041 .053
 Depression Depression+Ech -.20000 .04041 .000
Fig. 2: The effect of Echium amoenum 
aqueous extract on changes level 
CSF dopamine in different groups 
Fig. 1: The effect of Echium amoenum 
aqueous extract on changes level 
CSF serotonin in different groups
DISCUSSION
Impact of Echium amoenum aqueous extract on 
rat depression by evolution change level CSF 
serotonin 
 The lowering of in brain serotonin cause 
lower mood and enhancing in irritability or aggressive 
behaviors but the increasing concentration of 
serotonin possibly help to develop more constructive 
social interactions by reducing aggression and 
increasing dominance(17,18). Altered serotonin 
metabolism may be a highly magnify interfering 
factor aggression and suicide behavior in human, 
because reported earlier that lowering levels of 
cerebrospinal fluid 5-hydroxyindoleacetic acid (5-
HIAA), a serotonin metabolite cause these behaviors 
(19). Our finding showed which the level of CSF 
serotonin increased in depression group and control 
group treatment by Echium amoenum (Figure 1). 
Impact of Echium amoenum aqueous extract on 
rat depression by evaluation change level CSF 
dopamine 
 The studies revealed that depressive 
symptoms in schizophrenic patients are accossieted 
with a decrease in dopamine synthesis(20-22). 
The finding indicated that DA and DA D2 receptors 
play magnify role in the reinforcing responses to 
psycho stimulants in humans23.The studies Electro 
physiological demonstrated dopamine responses 
that consist predominantly of depressions24. 
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Vulgaris on primary dysmenorrhea in comparison to 
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demonstrated that the level CSF dopamine increased 
in depression group treatment by Echium amoenum 
(Figure 2), the results showed that anxiolytic effect 
of the extract Echium amoenum was most evident 
in 125 mg/kg group (6). Petals of E. amoenum have 
been advocated for its anxiolytic, sedative, anti-
inflammatory, demulcent and analgesic effects, 
particularly for common cold, in folk medicine of Iran 
(4-7). 
 Data analysis of the present study showed 
that the aqueous extract of Echium amoenum (125 
mg/kg) significantly increased the level of CSF 
serotonin and dopamine. The results suggests that 
Echium amoenum has effect antidepressant and 
enhancer mood , in part active with elevating level 
of CSF serotonin and dopamine as indicators mood. 
Althught arenot clear contributing mechanisms we 
suggest the researches continue with investigate 
effect Echium amoenum on changes level 
norepinephrine, GABA and other neurotransmitters 
as mood disorders indicators. 
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